首页|非酒精性脂肪性肝病中医诊疗专家共识(2023)

非酒精性脂肪性肝病中医诊疗专家共识(2023)

扫码查看
非酒精性脂肪性肝病是临床最常见的慢性肝病之一,中华中医药学会脾胃病分会于2009、2017年发布了《非酒精性脂肪性肝病中医诊疗共识意见》。近年来,中医药在非酒精性脂肪性肝病辨证治疗、证候规律研究等方面取得了积极进展,有必要对中医诊疗共识意见进行更新。本共识内容涵盖非酒精性脂肪性肝病的中西医诊断、病因病机、辨证论治方法、预防转归等,且总结了本病的现代医家经验、循证医学进展及疗效评价标准。本共识突出临床实用性,体现了最新研究进展,以期进一步提高中医药防治非酒精性脂肪性肝病的临床及科研水平。
Expert consensus on Traditional Chinese Medicine diagnosis and treatment of non-alcoholic fatty liver disease(2023)
Non-alcoholic fatty liver disease(NAFLD)is one of the most common chronic liver diseases in clin-ical practice.In 2009 and 2017,Branch of Gastrointestinal Diseases,China Association of Chinese Medicine re-leased the Expert Consensus on Traditional Chinese Medicine Diagnosis and Treatment of NAFLD.In recent years,Traditional Chinese Medicine has made significant progress in the syndrome differentiation and treatment of NAFLD.Therefore,it is necessary to update the consensus.This consensus covers the diagnosis,etiology and pathogenesis,syndrome differentiation and treatment,prevention and prognosis of NAFLD,and summarizes the experiences of modern medical experts,advancements in evidence-based medicine,and efficacy evaluation stand-ards as well.The consensus highlights its clinical practicality and reflects the latest research developments,aiming to further enhance the clinical and scientific research level of Traditional Chinese Medicine in the management of NAFLD.

non-alcoholic fatty liver diseaseTraditional Chinese Medicinetreatment based on syndrome dif-ferentiationconsensus

中华中医药学会脾胃病分会、季光、唐旭东

展开 >

非酒精性脂肪性肝病 中医 辨证论治 共识

上海市进一步加快中医药传承创新发展三年行动计划

ZY2021-2023-0211

2024

中国中西医结合消化杂志
华中科技大学同济医学院,中国中西医结合学会消化系统疾病专业委员会,中华中医药学会脾胃病专业委员会

中国中西医结合消化杂志

CSTPCD
影响因子:1.363
ISSN:1671-038X
年,卷(期):2024.32(1)
  • 29